215 related articles for article (PubMed ID: 9669944)
1. Toward HIV eradication or remission: the tasks ahead.
Ho DD
Science; 1998 Jun; 280(5371):1866-7. PubMed ID: 9669944
[No Abstract] [Full Text] [Related]
2. The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
Vandergeeten C; Fromentin R; Chomont N
Cytokine Growth Factor Rev; 2012; 23(4-5):143-9. PubMed ID: 22743037
[TBL] [Abstract][Full Text] [Related]
3. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
Finzi D; Hermankova M; Pierson T; Carruth LM; Buck C; Chaisson RE; Quinn TC; Chadwick K; Margolick J; Brookmeyer R; Gallant J; Markowitz M; Ho DD; Richman DD; Siliciano RF
Science; 1997 Nov; 278(5341):1295-300. PubMed ID: 9360927
[TBL] [Abstract][Full Text] [Related]
4. HIV survives drug onslaught by hiding out in T cells.
Balter M
Science; 1997 Nov; 278(5341):1227. PubMed ID: 9411749
[No Abstract] [Full Text] [Related]
5. Potential role of immune modulation in the effective long-term control of HIV-1 infection.
Rizzardi GP; Lazzarin A; Pantaleo G
J Biol Regul Homeost Agents; 2002; 16(1):83-90. PubMed ID: 12003181
[TBL] [Abstract][Full Text] [Related]
6. Ongoing HIV dissemination during HAART.
Grossman Z; Polis M; Feinberg MB; Grossman Z; Levi I; Jankelevich S; Yarchoan R; Boon J; de Wolf F; Lange JM; Goudsmit J; Dimitrov DS; Paul WE
Nat Med; 1999 Oct; 5(10):1099-104. PubMed ID: 10502799
[No Abstract] [Full Text] [Related]
7. Recovering from the ravages HIV.
Cohen J
Science; 1997 Jul; 277(5322):33. PubMed ID: 9229769
[No Abstract] [Full Text] [Related]
8. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Wong JK; Hezareh M; Günthard HF; Havlir DV; Ignacio CC; Spina CA; Richman DD
Science; 1997 Nov; 278(5341):1291-5. PubMed ID: 9360926
[TBL] [Abstract][Full Text] [Related]
9. The development of immune-modulating compounds to disrupt HIV latency.
Remoli AL; Marsili G; Battistini A; Sgarbanti M
Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
[TBL] [Abstract][Full Text] [Related]
10. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
11. The role of latency reversal agents in the cure of HIV: A review of current data.
Bashiri K; Rezaei N; Nasi M; Cossarizza A
Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
Siliciano JD; Siliciano RF
J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
[TBL] [Abstract][Full Text] [Related]
13. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
14. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
Pankrac J; Klein K; Mann JFS
AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
[TBL] [Abstract][Full Text] [Related]
15. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
[TBL] [Abstract][Full Text] [Related]
16. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
Pohlmeyer CW; Walker-Sperling VE; Blankson JN
Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
[No Abstract] [Full Text] [Related]
17. A reservoir for HIV in patients on combination antiretroviral therapy.
Siliciano RF
Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
[TBL] [Abstract][Full Text] [Related]
18. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.
Bucy RP
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752
[No Abstract] [Full Text] [Related]
19. IL-16 anti-HIV-1 therapy.
Viglianti GA; Parada NA; Maciaszek JW; Kornfeld H; Center DM; Cruikshank WW
Nat Med; 1997 Sep; 3(9):938. PubMed ID: 9288705
[No Abstract] [Full Text] [Related]
20. HIV/AIDS eradication.
Marsden MD; Zack JA
Bioorg Med Chem Lett; 2013 Jul; 23(14):4003-10. PubMed ID: 23735743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
